Variant report
Variant | nsv1027558 |
---|---|
Chromosome Location | chr7:126061271-126081173 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-ARF5-4 | chr7:126064175-126064239 | XLOC_006236 |
2 | lnc-ARF5-4 | chr7:126061482-126061634 | XLOC_006236 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs148267256 | chr7:126061542-126061543 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs567080121 | chr7:126061546-126061547 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs537639698 | chr7:126061615-126061616 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs549754090 | chr7:126061616-126061617 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs137895993 | chr7:126064175-126064176 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
6 | rs76849240 | chr7:126064188-126064189 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs190823997 | chr7:126064207-126064208 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
8 | rs182012083 | chr7:126064224-126064225 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs142272012 | chr7:126070810-126070811 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs546816898 | chr7:126070913-126070914 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs188290049 | chr7:126070920-126070921 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs536361677 | chr7:126070992-126070993 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs554238753 | chr7:126071033-126071034 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs569636959 | chr7:126071040-126071041 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs377689085 | chr7:126071074-126071075 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs570058313 | chr7:126071107-126071108 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs9918691 | chr7:126071111-126071112 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs146402691 | chr7:126071112-126071113 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs192981524 | chr7:126071151-126071152 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs555946841 | chr7:126071152-126071153 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs563704691 | chr7:126071202-126071203 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs556611881 | chr7:126071204-126071205 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs139750396 | chr7:126071207-126071208 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs144444433 | chr7:126071256-126071257 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs374171705 | chr7:126071273-126071274 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs9918568 | chr7:126071308-126071309 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
27 | rs535244673 | chr7:126071310-126071311 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs10487447 | chr7:126071383-126071384 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs10276326 | chr7:126071398-126071399 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs528792817 | chr7:126071419-126071420 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs9918707 | chr7:126071466-126071467 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs77953688 | chr7:126071467-126071468 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs529709597 | chr7:126071470-126071471 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs548276822 | chr7:126071486-126071487 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs182839138 | chr7:126071511-126071512 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs544124514 | chr7:126071550-126071551 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs578041966 | chr7:126071559-126071560 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs10487448 | chr7:126071605-126071606 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs34164328 | chr7:126071650-126071651 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs13242235 | chr7:126071651-126071652 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs146606276 | chr7:126071685-126071686 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs552843638 | chr7:126071696-126071697 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs574581764 | chr7:126071718-126071719 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs147678885 | chr7:126071743-126071744 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs150911914 | chr7:126071758-126071759 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs67025633 | chr7:126071759-126071760 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs71177551 | chr7:126071761-126071762 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs200516424 | chr7:126071762-126071763 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs187965381 | chr7:126071764-126071765 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs191105208 | chr7:126071791-126071792 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Biliary cancer | 19435499 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Prostate cancer | 23792589 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Non-small cell lung cancer | 19889201 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Autism | 18414403 | CNVD |
Autism | 19401682 | CNVD |
Autism | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Tourette syndrome | 19546859 | CNVD |
Melanoma | 19188590 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21509527 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Epilepsy | 21635232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
abnormal development | 18461090 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Autism | 20808228 | CNVD |
Autism | 19246517 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Cancer | 20164919 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 22522925 | CNVD |
Prostate cancer | 22341455 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:126070800-126071200 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
2 | chr7:126070800-126071400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr7:126070800-126071600 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
4 | chr7:126071400-126076200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr7:126076200-126076400 | Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr7:126076200-126076400 | Enhancers | Fetal Heart | heart |
7 | chr7:126076400-126076600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr7:126076400-126076800 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
9 | chr7:126076400-126076800 | Flanking Active TSS | Fetal Heart | heart |
10 | chr7:126076400-126077200 | Enhancers | Fetal Intestine Large | intestine |
11 | chr7:126076600-126076800 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
12 | chr7:126076600-126077200 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
13 | chr7:126076800-126077000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
14 | chr7:126076800-126077400 | Enhancers | Fetal Heart | heart |
15 | chr7:126076800-126081800 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
16 | chr7:126077000-126082000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
17 | chr7:126077200-126080200 | Weak transcription | Fetal Intestine Large | intestine |
18 | chr7:126077400-126077800 | Weak transcription | Fetal Heart | heart |
19 | chr7:126077400-126078200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
20 | chr7:126077800-126078000 | Enhancers | Fetal Heart | heart |
21 | chr7:126078000-126081800 | Weak transcription | Fetal Heart | heart |
22 | chr7:126080200-126081000 | Enhancers | Fetal Intestine Large | intestine |
23 | chr7:126081000-126082000 | Weak transcription | Fetal Intestine Large | intestine |